We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




MicroRNA Blocks Proapoptotic Genes in Mature Nerve Cells

By LabMedica International staff writers
Posted on 08 Feb 2011
Print article
A microRNA (miRNA) has been identified that blocks the activity of proapoptotic proteins in mature nerve cells and may be a potential drug for the treatment of neurodegenerative disorders.

During development, nerve cells that fail to connect to target tissues self-destruct. Yet, once such connections are made, surviving neurons become resistant to apoptosis for the life span of the organism.

Investigators at the University of North Carolina (Chapel Hill, USA) studied the mechanism underlying this radical change in behavior. They considered the class of gene-regulating molecules known as microRNAs to be a particularly promising target. To this end, they screened all known miRNAs to identify differences between immature and mature neurons.

Results published in the January 15, 2011, online edition of the journal Genes & Development revealed that the microRNA miR-29 was markedly induced with neuronal maturation. Immature neurons that would normally die became resistant to apoptosis following exposure to miR-29. Furthermore, analysis of brain tissues from patients with Alzheimer's disease or Huntington's disease showed reduced levels of miR-29.

The investigators reported that at the molecular level miR-29 blocked the activity of the genes that encode the BH3-only proapoptotic protein family. MiR-29 was able to inhibit several of these genes, circumventing a redundancy that allowed apoptosis to continue even if one of them had been blocked.

"There is the real possibility that this molecule could be used to block the cascade of events known as apoptosis that eventually causes brain cells to break down and die,” said senior author Dr. Mohanish Deshmukh, associate professor of cell and developmental biology at the University of North Carolina.

"People in the field have been perplexed that when they have knocked-out any one of these members it has not had a remarkable effect on apoptosis because there are others that can step in and do the job,” said Dr. Deshmukh. "The fact that this microRNA can target multiple members of this family is very interesting because it shows how a single molecule can basically in one stroke keep apoptosis from happening. Interestingly, it only targets the members that are important for neuronal apoptosis, so it may be a way of specifically preserving cells in the brain without allowing them to grow out of control (and cause cancer) elsewhere in the body.”

Related Links:
University of North Carolina

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automated Nucleic Acid Extractor
eLab
New
Quantitative Immunoassay Analyzer
AS050

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.